Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2015 Jul 3;5(11):1018–1027. doi: 10.1002/alr.21588

Table 2.

Comparison of baseline clinical measure of disease severity, health state utility values, missed days of productivity for across treatment modality for chronic rhinosinusitis

Medical
management
(n=40)
Surgical
intervention
(n=152)
Treatment
crossover
(n=20)
Clinical measures of disease severity: Mean [SD] Mean [SD] Mean [SD] p-value
Computed tomography (CT) score 13.3 [6.7] 13.1 [5.9] 13.0 [7.1] 0.985
Endoscopy score 6.6 [3.9] 6.5 [3.7] 8.4 [5.1] 0.293
Health state utility:
SF-6D value 0.76 [0.12] 0.70 [0.15] 0.69 [0.14] 0.069
Productivity:
Missed days (out of past 90) 4.2 [13.7] 9.6 [20.5] 8.3 [12.9] 0.017

SD, standard deviation;